<DOC>
	<DOCNO>NCT01128439</DOCNO>
	<brief_summary>This study estimate incidence invasive pneumococcal disease member Northern Kaiser Permanente healthcare system 5 follow introduction Prevnar 13 .</brief_summary>
	<brief_title>Study Estimating Impact Prevnar 13â„¢ ( 13vPnC ) Invasive Pneumococcal Disease</brief_title>
	<detailed_description>No sample subject enrol</detailed_description>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Documented invasive pneumococcal disease ( IPD ) , define recovery isolate S pneumoniae normally sterile site member surveillance population .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Pneumococcal conjugate vaccine</keyword>
</DOC>